Chinese Journal of Endocrinology and Metabolism 2009 Issue 2 The way in genetic research of the polygenic diseases

The way in genetic research of the polygenic diseases
FANG Fu-de

..............page:133-135

Association of gene polymorphism in promoter region of adiponectin gene and carotid artery intima-media thickness in patients with type 2 diabetes mellitus of Fujian
CAI Qing-yan;SHI Ya-xiong;LI Yong-jia;TAO Geng

..............page:136-138

Association of polymorphisms in transcription factor 7-like 2(TCF7L2) gene with type 2 diabetes in Chinese Han population
WANG Zhi-hong;ZHANG Su-hua;WANG Zeng-chan;GONG Li-lin;LI Rong;REN Wei;ZHENG Rui-zhi;WANG Mao-rong;ZHANG Wen-lu;CHENG Qing-feng;LIANG Song;WAN Xiao-li;ZHANG Lan-ying;HE Jun

..............page:139-143

Relationship between Calpain10 gene polymorphisms and diabetes in familial type 2 diabetes mellitus of Uygur in Xinjiang
FAN Yong;XIANMUSIYA·Rouzi;XIE Zi-jing;XIAO Yan;WANG Sai-gang

..............page:144-146

A functional analysis of short stature homeobox (SHOX) gene promoter mutation in idiopathic short stature
DONG Zhi-ya;DU Xiao-fei;WANG Wei;QIN Ke-nan;XIAO Yuan;WANG De-fen

..............page:147-149

Funcriohal analysis of novel mutations P459H and R483W in 21-hydroxylase gene
SONG Lu-lu;JIANG Ling;WANG Ji-ai;WANG Hui;ZHOU Hai-bin;ZHANG Xiao-li

..............page:150-151

Assessing new homeostasis model assessment by Botnia clamp
XIE Yun;LI Qi-fu;LI Bao-yi;FENG Jing;Qiu Yan

..............page:152-155

The waist-to-height ratio cut-point for identifying metabolic syndrome among adolescents
YIN Fu-zai;LU Qiang;MA Chun-ming;LIU Bo-wei;LOU Dong-hui;WANG Rui;HAN Gai-ling;WU Guang-fei;XUAN Xu-min;CHEN Hong;CAO Xiao-bin;WANG Min

..............page:156-158

Correlation between serum uric acid and cardiovascular risk factors in Shandong coastal inhabitants
WANG Yan-gang;YAN Sheng-li;LI Chang-gui;ZHAO Shi-hua;MIAO Zhi-min

..............page:159-163

Changes of biochemical markers of bone turnover and bone mineral density in mid- and old-aged women
LIU Hong;LIAO Er-yuan;WU Xian-ping;ZHANG Hong;XIE Hui;CAO Xing-zhi

..............page:164-167

Decrease in serum uric acid following achieving treat-to-target levels of glycemia,lipidemia and blood pressure in type 2 diabetic patients
LI Ming;ZHANG Li-na;PAN Qi;WANG Xiao-xia;LIU Xiao-ping;GUO Li-xin;WANG Yao

..............page:168-169

Levels of serum ferritin and hemoglobin in different stages of abnormal glycometabolism
ZHANG Chu;FENG Ye;LU Zhong;MA Li-zhen

..............page:170-171

Association of diabetic nephropathy with carotid intima-media thickness
WANG Guo-ping;DU Qun;WANG Guo;LANG Yin-zhi;LI Hua;GUO Xiao-yong;WU Hai-xia;ZHANG Yin-mei;HAO Livfang

..............page:172-173

Relationship between plasma level of endogenous secretory receptor of advanced glycation end products and oxidative stress in diabetic patients with hypertension
SHEN Xing-ping;ZOU Sen-biao;WU Haovjie;ZHANG Yan

..............page:174-176

Association of serum phosphohpid fatty acids with blood lipid profiles in patients with newly-diagnosed type 2 diabetes mellitus
LOU Da-jun;ZHU Qi-qian;MAO Xiao-yan;ZHANG Ai-zhen;LI Duo

..............page:176-178

Natural progression rate of glycometabalism in non-diabetic subjects aged above 40 years old-a 3 year prospective study in Pudong,Shanghai
TENG Xiang-yu;LIU Wei;CHENG qi;YANG Jie-jin;FANG Xue-min;HUANG Xuan

..............page:179-180

Epidemiological study of obesity in middle-aged and elderly people of Uygur and Han populations in xinjiang
ZHOU Xiao-hui;HONG Yu;LI Li;MAIMAITIMING Gulizaer;MIAO Hai-jun;HAO Chen-guang;MAIMAITI Maihebubaimu;MA Long

..............page:181-182

Preliminary investigation on blood-sampling time during oral glucose-insulin releasing test in subjects with normal glucose tolerance
ZHOU Wen-ring;LI Su-xiang;LI qing-ji;JIN Ai-lian;TENG Kui-xiang;JIN Zhen-chun;ZHANG Jin-shan

..............page:182-183

Analysis of factors affecting the prognosis of patients with Graves' disease treated with antithyroid drugs
YU Yi-kai;ZHANG Mu-zun;HU Shu-hong;SHUAI Hong-xia;ZHANG Ai-ping

..............page:184-185

α-lipoic acid inhibits the effects of Iκβ kinase β on islet
DONG Wei-ping;DING Xiao-ying;PENG Yong-de;CHENG Qun;WANG ru-fan;WANG ru-fei

..............page:186-188

Effects of GLP-1,Exendin-4 and C-peptide on renal blood flow in rats
WU Lin;ke Sjholm;GAO Xin

..............page:189-192

Effects of the dietary fat on adipose-associated gene expressions of adipocytes in mice
ZHANG Zhong;ZHANG Yi-hong;LI Qiang;QIAO Hong;SUN Yu-qian;ZHANG Jin-chao

..............page:193-196

Impact of human resistin on glucose uptake in adipocytes and its mechanism
SHENG Chun-hua;JIN Yong;ZHANG Ying-hong;GAO Shen;BU Li-sha;YANG Shao-Juan;ZHANG Gui-zhen

..............page:197-199

Insulin reverses fatty liver disease in diabetic mice induced with high fat diet
ZHU Yan-hun;CHEN Xiang;LI Ming;Yu Qiu-qiong;SUN Wei-Ping;BI Yan;WENG Jian-Ping

..............page:200-202

Effect of the unbalanced expressions of VEGF and PEDF on diabetic nephropathy
LI Jing;LI Zhen-jin;CUI Jing;WANG Shu-e;BAO Yan;YE Ying-chun

..............page:203-205

Relationship between insulin resistance and oxidative stress caused by elevated concentration of free fatty acids
LU Zhi-ming;YU Ye-rong;WANG Chun;ZHANG Xiang-xun

..............page:205-207

Musclin gene overexpression in skeletal muscle of rats with long-term high-fat diet and its correlation with insulin resistance
CAO Ling-ling;YUAN Li;XU Jiang-xiang;LIU Zhi-qiang;WANG Xia;ZHANG Bei;QIU Hai-yan;XU Guo-ling;TANG Zhao-sheng

..............page:208-209

Effect of angiotensin receptor blocker on the expressions of NF-κB PPARγ in adipose tissue of high-fat- diet induced insulin resistant rats
LIU Xiao-ling;YUAN Li;GUO Cai-hong;HUANG Yan;DU Ai-min;ZHANG Li-li

..............page:210-211

The genetics of type 2 diabetes: A realistic appraisal in 2008
hu cheng ; wang zuo ; jia wei ping

..............page:212-214

Prevention and treatment of pediatric obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion
gui ming hui ; ling yan ; gao zuo

..............page:215-217

Treatment of pediatric obesity: A systematic review and meta-analysis of randomized trials
gu wei qiong ; chen ming dao

..............page:217-219

Gestational diabetes: An opportunity for improvement
liu zuo jing ; zhang yi wen

..............page:220

Approach to the patient with a cytologically indeterminate thyroid nodule
guo jian jin ; liu chao

..............page:221-223

Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: A metaanalysis
yuan wen zuo ; wang wei qing

..............page:224-226

Mechanism for improved insulin sensitivity after gastric bypass surgery
li ping ; chen ming dao

..............page:226-229

Iodine 131 and lingual thyroid
geng yuan yuan ; gao shuo

..............page:229

One case of hyperthyroidism crisis,diabetes mellitus,jaundice,amyasthenia complicated with diffuse intravascular coagulation
ZHENG Fang-qiu;FAN Ji-yuan;LIU Wei;GAO Zhi-hong;QIU Ming-cai

..............page:230-231

One case of hypoparathyroidism and hypothyroidism with increased myocardial enzymes
GUO Zhi-xin

..............page:232-233

Progress of pharmacogenomic studies on anti-diabetic drugs
WANG Jie;JIA Wei-ping

..............page:234-237

Influential factors on the ratio of plasma aldosterone concentration to plasma renin activity in screening primary aldosteronism
YIN Guo-shu;ZHANG Shao-ling;YAN Li;CHENG Hua

..............page:238-241

Aversion to sweet-tasting foods,palpitation and debilitation Hereditary fructose intolerance
CHI Zhen-ni;HONG Jie;YANG Jun;ZHANG Hui-jie;DAI Meng;GU Wei-qiong;ZIIANG Yi-fei;WANG Wei-qing;LI Xiao-ying;NING Guang

..............page:242-244

The prevention of cardiovascular events should begin with the focus on IGT
WENG Jian-ping

..............page:增录2a-1-增录2a-3

Acarbose Cardiovascular Evaluation:A new phase of hyperglycemia management in coronary heart disease
PAN Chang-yu

..............page:增录2a-3-增录2a-5

Retrospective of Acarbose (Glucobay(R)) administration experience in China and its prospectives
LU Ju-ming

..............page:增录2a-6-增录2a-8

GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Supplement
P Ambery;AR Cobitz

..............page:增录2b-1

Understanding 《 GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes》 Supplement
PAN Chang-yu

..............page:增录2b-2

Pancreatic β-cell and insulin secretion——plasticity and decompensation?
PAN Chang-yu

..............page:增录2c-1-增录2c-3

The impaired insulin secretion and β-cell failure in type 2 diabetes
GUO Xiao-hui

..............page:增录2c-4-增录2c-6